ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

RVPHW Reviva Pharmaceuticals Holdings Inc

0.1698
0.0156 (10.12%)
18 Jan 2025 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 37,970
Bid Price 0.16
Ask Price 0.25
News -
Share Name Share Symbol Market Stock Type
Reviva Pharmaceuticals Holdings Inc RVPHW NASDAQ Equity Warrant
  Price Change Price Change % Share Price Last Trade
0.0156 10.12% 0.1698 16:00:08
Open Price Low Price High Price Close Price Previous Close
0.1835 0.155 0.1898 0.1698 0.1542
Trades Shares Traded VWAP Financial Volume Average Volume
102 37,970  0.1669269  6,338 -
Last Trade Type Quantity Price Currency
08:00:00 2,500  0.17 USD

Reviva Pharmaceuticals Holdings Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.49M 22.65M - 0 -39.26M -1.73 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Reviva Pharmaceuticals

Date Time Source Heading
21/12/202408:30Edgar (US Regulatory)Form SCHEDULE 13D/A - General Statement of Acquisition of..
18/12/202422:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
17/12/202409:18Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]
17/12/202400:10Edgar (US Regulatory)Form 8-K - Current report
13/12/202408:36Edgar (US Regulatory)Form 8-K - Current report
13/12/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
13/12/202408:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
13/12/202408:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of..
15/11/202409:25Edgar (US Regulatory)Form 8-K - Current report
15/11/202409:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202400:30Edgar (US Regulatory)Form 8-K - Current report
29/10/202407:17Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statements

RVPHW Historical

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

NASDAQ:RVPHW -

What is the current Reviva Pharmaceuticals Holdings Inc share price?
The current share price of Reviva Pharmaceuticals Holdings Inc is US$ 0.1698
How many Reviva Pharmaceuticals Holdings Inc shares are in issue?
Reviva Pharmaceuticals Holdings Inc has 22,650,000 shares in issue
What is the market cap of Reviva Pharmaceuticals Holdings Inc?
The market capitalisation of Reviva Pharmaceuticals Holdings Inc is USD 3.49M
What is the 1 year trading range for Reviva Pharmaceuticals Holdings Inc share price?
Reviva Pharmaceuticals Holdings Inc has traded in the range of US$ 0.00 to US$ 0.00 during the past year
What is the PE ratio of Reviva Pharmaceuticals Holdings Inc?
The price to earnings ratio of Reviva Pharmaceuticals Holdings Inc is -5.05
What is the reporting currency for Reviva Pharmaceuticals Holdings Inc?
Reviva Pharmaceuticals Holdings Inc reports financial results in USD
What is the latest annual profit for Reviva Pharmaceuticals Holdings Inc?
The latest annual profit of Reviva Pharmaceuticals Holdings Inc is USD -39.26M
What is the registered address of Reviva Pharmaceuticals Holdings Inc?
The registered address for Reviva Pharmaceuticals Holdings Inc is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Reviva Pharmaceuticals Holdings Inc website address?
The website address for Reviva Pharmaceuticals Holdings Inc is revivapharma.com
Which industry sector does Reviva Pharmaceuticals Holdings Inc operate in?
Reviva Pharmaceuticals Holdings Inc operates in the PHARMACEUTICAL PREPARATIONS sector